Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Endogenous peptide hormone, involved in growth ...
Aminoglycoside; protein translation inhibitor, ...
K+-sparing diuretic; ENaC and acid-sensing ion ...
Imidzoline derivative; MDM2 inhibitor.
Indole, glucosinolate found in cruciferous vege...
Aromatic 1,3-diketone acetylacetone derivative ...
FIASMA, histamine H1 inverse agonist, 5-HT2A, D...
Taxol derivative.
Benzothiazole; TRPC5 agonist, PTR1 inhibitor, v...
Allylamine; squalene oxidase and KSR1 inhibitor...
Non-competitive inhibitor of xanthine oxidase.<...
Peptide, substance P analog; NK agonist.
Non-depolarizing NMJ blocker; AChR antagonist.<...
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Endogenous peptide hormone, involved in feeding...
Alkaloid produced by Streptomyces, DNA cross-li...
Pyrrolidone; NMDA and mGluR5 agonist, N-type an...
Inhibitor of BMP.
FGFR inhibitor.
Endogenous pteridine metabolite of GTP.